![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Factors influencing the effect of radioimmunotherapy on liver cancer
Factors influencing the therapeutic effect of radioimmunotherapy with131I labeled anti-human hepa tocellular carcinoma (HCC) ferritin antibody (131I-FtAb) on thirty three patients with surgically proven unresecta...
-
Article
Radioiodinated anti-hepatocellular carcinoma (HCC) ferritin Targeting therapy, tumor imaging and anti-antibody response in HCC patients with hepatic arterial infusion
Radioimmunoimaging and radioimmunotherapy with radioiodinated anti-(hepatocellular carcinoma ferritin) antibody (131I-or125I-FtAb) have been applied in patients with primary liver cancer. A total of 41 patients w...
-
Article
Conversion of surgically verified unresectable to resectable hepatocellular carcinoma
During the period 1978–1987, 255 patients with pathologically proven hepatocellular carcinoma (HCC) were determined by laparotomy to be unresectable, 155 (60.8%) out of them had their tumor mainly confined in ...